SE9302218D0 - New use - Google Patents

New use

Info

Publication number
SE9302218D0
SE9302218D0 SE19939302218A SE9302218A SE9302218D0 SE 9302218 D0 SE9302218 D0 SE 9302218D0 SE 19939302218 A SE19939302218 A SE 19939302218A SE 9302218 A SE9302218 A SE 9302218A SE 9302218 D0 SE9302218 D0 SE 9302218D0
Authority
SE
Sweden
Prior art keywords
pct
sec
date
new use
pub
Prior art date
Application number
SE19939302218A
Other languages
English (en)
Inventor
Torsten *Eek Arne
Original Assignee
Ab Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20390432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE9302218(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ab Astra filed Critical Ab Astra
Priority to SE19939302218A priority Critical patent/SE9302218D0/sv
Publication of SE9302218D0 publication Critical patent/SE9302218D0/sv
Priority to BR9406865A priority patent/BR9406865A/pt
Priority to PL94312198A priority patent/PL175518B1/pl
Priority to PCT/SE1994/000496 priority patent/WO1995000148A1/en
Priority to CA002165446A priority patent/CA2165446C/en
Priority to SG1996005829A priority patent/SG49078A1/en
Priority to HU9503692A priority patent/HU218949B/hu
Priority to DK94919912T priority patent/DK0706395T3/da
Priority to CN94192664A priority patent/CN1074918C/zh
Priority to DE69430427T priority patent/DE69430427T2/de
Priority to ES94919912T priority patent/ES2099048T3/es
Priority to DE0706395T priority patent/DE706395T1/de
Priority to AU70866/94A priority patent/AU692161C/en
Priority to AT94919912T priority patent/ATE216237T1/de
Priority to EP94919912A priority patent/EP0706395B1/en
Priority to PT94919912T priority patent/PT706395E/pt
Priority to US08/256,319 priority patent/US5670524A/en
Priority to SK1646-95A priority patent/SK280111B6/sk
Priority to NZ268110A priority patent/NZ268110A/xx
Priority to CZ953364A priority patent/CZ283300B6/cs
Priority to JP50268795A priority patent/JP3725541B2/ja
Priority to RU96101169/14A priority patent/RU2152215C1/ru
Priority to TW083105008A priority patent/TW285640B/zh
Priority to IS4174A priority patent/IS4174A/is
Priority to PH48413A priority patent/PH31258A/en
Priority to IL11000694A priority patent/IL110006A/en
Priority to SA94150010A priority patent/SA94150010B1/ar
Priority to LTIP1958A priority patent/LT3449B/lt
Priority to MYPI94001663A priority patent/MY119360A/en
Priority to EE9400347A priority patent/EE03205B1/xx
Priority to NO955313A priority patent/NO955313L/no
Priority to FI956269A priority patent/FI956269A/sv
Priority to US08/851,062 priority patent/US5834489A/en
Priority to GR970300013T priority patent/GR970300013T1/el
Priority to HK98111303A priority patent/HK1010344A1/xx
Priority to LVP-02-131A priority patent/LV12918B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
SE19939302218A 1993-06-28 1993-06-28 New use SE9302218D0 (sv)

Priority Applications (36)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use
JP50268795A JP3725541B2 (ja) 1993-06-28 1994-05-26 ロピバカインを含有する医薬製剤
RU96101169/14A RU2152215C1 (ru) 1993-06-28 1994-05-26 Применение ропивакаина при изготовлении фармацевтического препарата с анальгезирующим действием с минимальной моторной блокадой
PT94919912T PT706395E (pt) 1993-06-28 1994-05-26 Uso de ropivacaina na preparacao duma composicao farmaceutica com efeito analgesico e bloqueio motor minimo
NZ268110A NZ268110A (en) 1993-06-28 1994-05-26 Use of ropivacaine salt in pharmaceutical compositions for the treatment of pain with sensoric block and minimal motor blockage
PCT/SE1994/000496 WO1995000148A1 (en) 1993-06-28 1994-05-26 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
CA002165446A CA2165446C (en) 1993-06-28 1994-05-26 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
SG1996005829A SG49078A1 (en) 1993-06-28 1994-05-26 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
HU9503692A HU218949B (hu) 1993-06-28 1994-05-26 Ropivakain alkalmazása minimális motoros blokád hatással rendelkező, fájdalomcsillapító hatású gyógyszerkészítmény előállítására
DK94919912T DK0706395T3 (da) 1993-06-28 1994-05-26 Lægemiddel med analgetisk effekt med minimal bevægelsesblokade
CN94192664A CN1074918C (zh) 1993-06-28 1994-05-26 罗哌卡因在具有最小运动神经阻断的止痛作用的药物制造中的应用
DE69430427T DE69430427T2 (de) 1993-06-28 1994-05-26 Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade
ES94919912T ES2099048T3 (es) 1993-06-28 1994-05-26 Uso de ropivacaina en la fabricacion de un producto farmaceutico con efecto analgesico y con bloqueo motor minimo.
DE0706395T DE706395T1 (de) 1993-06-28 1994-05-26 Verwendung von ropivacaine zur herstellung eines analgetikmus mit minimaler motorischer blockade
AU70866/94A AU692161C (en) 1993-06-28 1994-05-26 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
AT94919912T ATE216237T1 (de) 1993-06-28 1994-05-26 Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade
EP94919912A EP0706395B1 (en) 1993-06-28 1994-05-26 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
BR9406865A BR9406865A (pt) 1993-06-28 1994-05-26 Uso de um sal farmaceuticamente aceitável de ropivacaina na fabricaçao de um produto farmaceutico processo para o tratamento de uma pessoa necessitando de alivio da dor e preparaçao farmaceutica
US08/256,319 US5670524A (en) 1993-06-28 1994-05-26 Methods and compositions for the treatment of pain utilizing ropivacaine
SK1646-95A SK280111B6 (sk) 1993-06-28 1994-05-26 Použitie ropivakaínu na výrobu farmaceutického pro
PL94312198A PL175518B1 (pl) 1993-06-28 1994-05-26 Preparat farmaceutyczny do leczenia ostrego bólu drogą blokady czuciowej i sposób wytwarzania preparatu farmaceutycznego
CZ953364A CZ283300B6 (cs) 1993-06-28 1994-05-26 Použití ropivakcinu pro výrobu farmaceutického prostředku s analgetickou účinností s minimální motorickou blokádou
TW083105008A TW285640B (sv) 1993-06-28 1994-06-01
IS4174A IS4174A (is) 1993-06-28 1994-06-08 Ný notkun á lyfjafræðilega viðurkenndu salti
PH48413A PH31258A (en) 1993-06-28 1994-06-09 New use of ropivacaine.
IL11000694A IL110006A (en) 1993-06-28 1994-06-13 Pharmaceutical preparations with sensor and minimal motor blockage containing rupiocaine salts
SA94150010A SA94150010B1 (ar) 1993-06-28 1994-06-14 طريقة وتركيبات لعلاج الألم باستخدام روبيفاكين ropivacaine
LTIP1958A LT3449B (en) 1993-06-28 1994-06-17 New use of ropivacaine
MYPI94001663A MY119360A (en) 1993-06-28 1994-06-27 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
EE9400347A EE03205B1 (et) 1993-06-28 1994-11-03 Ropivakaiini kasutamine valuvaigistina kasutatava ravimpreparaadi valmistamiseks
NO955313A NO955313L (no) 1993-06-28 1995-12-27 Anvendelse av ropivacain i fremstillingen av et farmasöytikum med analgetisk effekt som har minimal motorisk blokkering
FI956269A FI956269A (sv) 1993-06-28 1995-12-27 Användning av ropivacainet vid tillverkning av ett farmaceutiskt preparat med anagetisk verkan med minimal motorisk blockad
US08/851,062 US5834489A (en) 1993-06-28 1997-05-05 Methods and compositions for the treatment of pain utilizing ropivacaine
GR970300013T GR970300013T1 (en) 1993-06-28 1997-05-30 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
HK98111303A HK1010344A1 (en) 1993-06-28 1998-10-19 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
LVP-02-131A LV12918B (en) 1993-06-28 2002-07-15 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use

Publications (1)

Publication Number Publication Date
SE9302218D0 true SE9302218D0 (sv) 1993-06-28

Family

ID=20390432

Family Applications (1)

Application Number Title Priority Date Filing Date
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use

Country Status (33)

Country Link
US (2) US5670524A (sv)
EP (1) EP0706395B1 (sv)
JP (1) JP3725541B2 (sv)
CN (1) CN1074918C (sv)
AT (1) ATE216237T1 (sv)
BR (1) BR9406865A (sv)
CA (1) CA2165446C (sv)
CZ (1) CZ283300B6 (sv)
DE (2) DE706395T1 (sv)
DK (1) DK0706395T3 (sv)
EE (1) EE03205B1 (sv)
ES (1) ES2099048T3 (sv)
FI (1) FI956269A (sv)
GR (1) GR970300013T1 (sv)
HK (1) HK1010344A1 (sv)
HU (1) HU218949B (sv)
IL (1) IL110006A (sv)
IS (1) IS4174A (sv)
LT (1) LT3449B (sv)
LV (1) LV12918B (sv)
MY (1) MY119360A (sv)
NO (1) NO955313L (sv)
NZ (1) NZ268110A (sv)
PH (1) PH31258A (sv)
PL (1) PL175518B1 (sv)
PT (1) PT706395E (sv)
RU (1) RU2152215C1 (sv)
SA (1) SA94150010B1 (sv)
SE (1) SE9302218D0 (sv)
SG (1) SG49078A1 (sv)
SK (1) SK280111B6 (sv)
TW (1) TW285640B (sv)
WO (1) WO1995000148A1 (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
EP0998286A2 (en) * 1997-07-21 2000-05-10 Darwin Discovery Limited Use of levobupivacaine
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
WO2009061497A1 (en) * 2007-11-07 2009-05-14 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
CA2873138A1 (en) * 2012-05-10 2013-11-14 Cellixbio Private Limited Compositions and methods for the treatment of local pain
CA2871820C (en) * 2012-05-10 2020-11-03 Painreform Ltd. Depot formulations of a hydrophobic active ingredient and methods for preparation thereof
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
JP6114841B2 (ja) 2013-02-28 2017-04-12 ダーミラ， インク．Ｄｅｒｍｉｒａ， Ｉｎｃ． グリコピロレート塩
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560367B2 (en) * 1983-08-01 1987-04-02 Astra Lakemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use

Also Published As

Publication number Publication date
ES2099048T3 (es) 2002-11-16
IS4174A (is) 1994-12-29
SK164695A3 (en) 1996-07-03
EP0706395B1 (en) 2002-04-17
EE03205B1 (et) 1999-08-16
SG49078A1 (en) 1998-05-18
DE69430427D1 (de) 2002-05-23
AU692161B2 (en) 1998-06-04
CA2165446C (en) 2005-07-05
DE706395T1 (de) 1997-09-04
ES2099048T1 (es) 1997-05-16
LTIP1958A (en) 1995-01-31
JPH09500620A (ja) 1997-01-21
JP3725541B2 (ja) 2005-12-14
IL110006A0 (en) 1994-11-11
CA2165446A1 (en) 1995-01-05
CN1074918C (zh) 2001-11-21
DK0706395T3 (da) 2002-07-22
DE69430427T2 (de) 2002-11-14
HU218949B (hu) 2001-01-29
HUT75115A (en) 1997-04-28
MY119360A (en) 2005-05-31
HK1010344A1 (en) 1999-06-17
SK280111B6 (sk) 1999-08-06
CZ283300B6 (cs) 1998-02-18
CZ336495A3 (en) 1996-06-12
PL312198A1 (en) 1996-04-01
US5834489A (en) 1998-11-10
BR9406865A (pt) 1996-03-26
LT3449B (en) 1995-10-25
NO955313D0 (no) 1995-12-27
GR970300013T1 (en) 1997-05-31
AU7086694A (en) 1995-01-17
TW285640B (sv) 1996-09-11
FI956269A0 (sv) 1995-12-27
CN1126435A (zh) 1996-07-10
PH31258A (en) 1998-06-18
IL110006A (en) 1999-01-26
HU9503692D0 (en) 1996-02-28
LV12918B (en) 2003-03-20
NZ268110A (en) 1999-06-29
RU2152215C1 (ru) 2000-07-10
PL175518B1 (pl) 1999-01-29
EP0706395A1 (en) 1996-04-17
ATE216237T1 (de) 2002-05-15
WO1995000148A1 (en) 1995-01-05
PT706395E (pt) 2002-09-30
SA94150010B1 (ar) 2006-04-04
FI956269A (sv) 1995-12-27
US5670524A (en) 1997-09-23
NO955313L (no) 1995-12-27

Similar Documents

Publication Publication Date Title
NO960067D0 (no) Nytt farmasöytisk preparat
RS50485B (sr) Terapeutske kombinacije koje sadrže amplodipin i atorvastatin
SE9401728D0 (sv) New compounds II
SE9302218D0 (sv) New use
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
ZA965749B (en) Use of allylamines.
SE9404438D0 (sv) New process
SE9501773D0 (sv) New use
KR960700053A (ko) 방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer)